Table 3.

Logistic regression on likelihood of QUIET 9 concordant care among new epilepsy cases (N = 3,706), 2009

	OR (CI)
Race/ethnicity (ref White)
African American	0.81 (0.66–1.00)
Hispanic	0.92 (0.70–1.21)
Asian	1.39 (0.99–1.96)
AI/ANa	0.93 (0.55–1.57)
Gender (ref Male)
Female	1.20 (1.04–1.40)
Age in 2009 (ref 67–74)
75–84	1.04 (0.88–1.22)
85+	1.19 (0.99–1.42)
Comorbid conditions (ref None)
1–3	0.92 (0.63–1.35)
4+	0.96 (0.66–1.41)
Seen neurologist close to the index event (ref No neurologist)	1.83 (1.56–2.13)
LISb eligible (ref Not eligible)	0.91 (0.75–1.10)
Part D Coverage Phasec (ref Deductible)
Copay/coinsurance	1.41 (1.17–1.71)
Coverage gap (donut hole)	1.57 (1.23–2.00)
Catastrophic coverage	1.73 (1.18–2.53)
No phase	2.15 (1.36–3.41)
Region of residence (ref Northeast)
Other than northeast	0.70 (0.58–0.84)
ZIP code area
High Povertyd	0.85 (0.73–0.98)
Number of observations used	3562

^aAI/AN= American Indian/Alaskan Native;

^bLow Income Subsidy;

^cCoverage phase for the drug prescribed before the first observed AED;

^d20% or more households below the Federal Poverty Line